Clinical Trial Update: Linezolid Dosing Strategies in Drug-Resistant TB [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating linezolid dosing strategies for drug-resistant tuberculosis. The study is currently listed as ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis
• Tuberculosis Multidrug-resistant
• Tuberculosis Pulmonary

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, Multidrug-Resistant, Tuberculosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING